MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2016 International Congress

June 19-23, 2016. Berlin, Germany.

View by Title View Sessions
View by Date
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • Dopamine modulates learning conflicting action-valence associations in Parkinson’s disease

    N.C. van Wouwe, D.O. Claassen, J.S. Neimat, S.A. Wylie (Nashville, TN, USA)

  • Dopamine reduces Parkinson’s tremor through increased thalamic inhibition

    M.F. Dirkx, H.E. den Ouden, E. Aarts, M. Timmer, B.R. Bloem, I. Toni, R.C. Helmich (Nijmegen, Netherlands)

  • Dopamine transporter, depression and anxiety differences between tremor-predominant and non-tremulous PD are already evident within 2 years of PD diagnosis

    Q. Hu, F. Zhou, C.P. Jedynak, L.S. Rosenthal, Z. Mari, B.M. Jedynak (Baltimore, MD, USA)

  • Dopaminergic and metabolic network activities in onset-related subtypes of Parkinson’s disease: A dual-tracer positron emission tomography study

    F.T. Liu, J.J. Ge, J.J. Wu, Z.T. Ding, C.T. Zuo, J. Wang (Shanghai, People's Republic of China)

  • Dopaminergic and non-dopaminergic effects on instrumented timed up and go test in patients with Parkinson’s disease

    V. Dibilio, A. Nicoletti, G. Mostile, S. Toscano, A. Luca, L. Raciti, R. Vasta, C.E. Cicero, D. Contrafatto, M. Zappia (Catania, Italy)

  • Dopaminergic drug management in Parkinson’s disease: Gait and language function show correlation during treatment

    H. Murakami, A. Futamura, T. Kuroda, S. Ishigaki, M. Kezuka, K. Ono, M. Kawamura (Tokyo, Japan)

  • Dopaminergic medication affects choice bias in Parkinson’s disease

    A.J.M. van Nuland, R.C.G. Helmich, M. Dirkx, H. Zach, B.R. Bloem, I. Toni, R. Cools, H.E.M. den Ouden (Nijmegen, Netherlands)

  • Dopaminergic medication effect on speech in Parkinson’s disease: A kinematic study

    T.E. Tong, M.L. Ng, N. Yan (Hong Kong, Hong Kong)

  • Dopaminergic medicines are alternative drugs for treatment of motor disorders in ischemic stroke

    A. Azimov, R. Sadykov, G. Rakhimbaeva, S. Dadajonov, O. Azizova (Tashkent, Uzbekistan)

  • Dophaminergic therapy and its influence on the olfactory function of patients with Parkinson’s disease

    O. Izhboldina, I. Zhukova, N. Zhukova, V. Alifirova, A. Latypova, M. Nikitina, Y. Mironova (Tomsk, Russia)

  • « Previous Page
  • 1
  • …
  • 61
  • 62
  • 63
  • 64
  • 65
  • …
  • 207
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley